• Home
  • News
  • Sport
  • Politics
  • Column
  • Business
  • Life & Style
    • Crime
    • R&D Health
    • Diet and Fitness
    • Intimacy
  • Entertainment
    • Photos
    • Fashion
    • Movies
    • Music
  • Videos
Facebook Twitter Instagram
Trending
  • Call Nwoye now to congratulate him, Anambra group tasks Senator Oduah
  • Egg glut: Poultry farmers appeal to government to mop up produce
  • Buhari condoles with family of 94-year-old retired police officer, Mary Iyabode Abebi Oyebade
  • Polls: Fani-Kayode attacks British Deputy High Commissioner
  • Police launch manhunt for gunmen who killed policemen at checkpoint
  • Police arrest 79 suspected election violators in Sokoto
  • Journalist’s daughter emerges best medical student at UNIZIK
  • I was made mouth watering offers to step down — Teacher who floored Yobe Speaker
Facebook Twitter Instagram
The Eagle OnlineThe Eagle Online
  • Home
  • News
  • Sport
  • Politics
  • Column
  • Business
  • Life & Style
    • Crime
    • R&D Health
    • Diet and Fitness
    • Intimacy
  • Entertainment
    • Photos
    • Fashion
    • Movies
    • Music
  • Videos
The Eagle OnlineThe Eagle Online
Home»Featured»COVID-19: NAFDAC warns against use of Chloroquine
Featured

COVID-19: NAFDAC warns against use of Chloroquine

NANBy NANMay 14, 2020No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

The National Agency for Food and Drug Administration and Control has, again, warned Nigerians against taking Chloroquine as treatment for Coronavirus Disease.

“Nobody should buy Chloroquine and use. If you have COVID-19, go to a doctor. We have warned Nigerians and shall do that again. Do not take Chloroquine,” Prof. Mojisola Adeyeye, NAFDAC’s Director General, told the News Agency of Nigeria on Thursday in Abuja.

She added: “The delay in approving some of the drugs for treatment of the virus is because of the clinical trials the agency is carrying out on them.

“So far, no group or individual has proffered any solution to the treatment or management of the pandemic.”

According to Adeyeye, the Chinese Government carried out lots of trials on Chloroquine before it approved its use for treatment on some COVID-19 patients.

She said: “Clinical trial is not a thing one can handle casually; it requires guidance, supervision and experiment before approval so that it will not cause further damage.

“The trial is to determine whether it is actually working or not, after a sustained observation. NAFDAC is supposed to be the centre of the regulation of clinical trial effects.

“Nobody can do any job of clinical trial in the clinic or anywhere without passing through NAFDAC protocol.

”If such protocol is found defective or tend to compromise the health of Nigerians, we will not approve it.”

The NAFDAC boss further said that whatever procedure was coming up for the cure or curtailment of COVID-19 must be submitted for trial to the agency for appropriate processing.

Adeyeye said the agency must also ensure that all the procedure used in arriving at their experimental processes for the cure or curtailment of COVID-19 must be submitted with relevant proof.

Adeyeye advised researchers and traditional medical practitioners to follow the normal protocol before the approval of their work for public consumption.

chloroquine COVID-19 National Agency for Food and Drug Administration and Control
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
NAN

Related Posts

Egg glut: Poultry farmers appeal to government to mop up produce

March 27, 2023

Polls: Fani-Kayode attacks British Deputy High Commissioner

March 27, 2023

Police launch manhunt for gunmen who killed policemen at checkpoint

March 27, 2023
© 2023 All Rights Reserved. The Eagle Online.
  • Home
  • Privacy Policy
  • Advert Rates
  • Submit News
  • Contact Us

Type above and press Enter to search. Press Esc to cancel.